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Abstract 
Objective: This study examined cortisol in adolescents with chronic fatigue syndrome (CFS) compared to 
healthy adolescents and changes in cortisol after cognitive behavioural guided self-help treatment. 
Exploratory analyses investigated the association between cortisol output and psychological variables. 
Methods: Salivary cortisol was measured upon awakening, at 15, 30, 45 and 60 mins afterwards and at 12 
noon, 4pm and 8pm, in adolescents with CFS and healthy controls (HC). Groups were matched for age, 
gender, menarche status, menstrual cycle and awakening time. Twenty-four adolescents with CFS provided 
saliva samples six months after treatment. The main outcome measure was total salivary output over the day, 
calculated by area under the curve (AUC). The salivary awakening response was also assessed. 
Results: Cortisol output over the day was significantly lower in the CFS group (n=46) than in healthy 
controls (n=33). Within the CFS group, lower daily cortisol output was associated with higher self-reported 
perfectionist striving and prosocial behaviour. There were no significant group differences in the awakening 
response (n=47 CFS versus n=34 HC). After treatment, adolescents with CFS (n=21) showed a significant 
increase in daily cortisol output, up to normal levels.  
Conclusion: The reduced daily cortisol output in adolescents with CFS is in line with adult findings. 
Associations between reduced cortisol output and two psychological variables - perfectionism and prosocial 
behaviour - are consistent with cognitive behavioural models of chronic fatigue syndrome. The mild 
hypocortisolism is reversible; cortisol output had returned to healthy adolescent levels by six months after 
cognitive behavioural guided self-help treatment.   
 
Keywords: fatigue, youth, paediatric, hypothalamic-pituitary-adrenal axis, neuroendocrine, perfectionism. 
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INTRODUCTION 
 
Chronic fatigue syndrome (CFS) is likely to be a multifactorial condition in which biological, psychological 
and social factors contribute and interact. Few biological changes have been reliably demonstrated in this 
condition, one of the exceptions being disturbed hypothalamic-pituitary-adrenal (HPA) axis dysfunction 
(Papadopoulos & Cleare, 2012).  In adults with CFS, reduced cortisol output over the day has been 
demonstrated in salivary and urinary cortisol studies (Jerjes, Cleare, Wessely, Wood & Taylor, 2005; Jerjes, 
Peters, Taylor, Wessely & Cleare, 2006; Tak et al., 2011). In adults there is also evidence of an attenuation 
of the usual rapid increase in salivary cortisol levels after awakening (Roberts, Chalder, Papadopoulos & 
Cleare, 2004). The cortisol awakening response is not well understood but appears to be influenced by a 
number of factors in addition to HPA activation, such as sensitivity to light mediated by an extra-pituitary 
pathway (e.g. Clow, Hucklebridge, Stalder, Evans and Thorn, 2010). Therefore it is important not to rely 
only on measures of the cortisol awakening response to assess HPA axis activation. 
 
Reduced cortisol may be a primary etiological factor in CFS and / or secondary to sleep disturbance, reduced 
activity or other factors commonly associated with CFS such as increased stress or distress. Stress is reported 
by some young people with CFS as a contributory factor to their condition (Gray & Rutter, 2007) and there 
are elevated rates of mood and anxiety problems in adolescents with CFS compared to young people with 
other chronic illness (e.g. Bould, Collin, Lewis, Rimes & Crawley, 2013; Rangel, Garralda, Hall & 
Woodham, 2003). Chronic stress is associated with hypocortisolism (Miller, Chen & Zhou 2007) and a study 
in adults with CFS found that blunted cortisol awakening responses were only present in those with a history 
of childhood trauma (Heim et al., 2009). It has been suggested that hypocortisolism can reflect a protective 
response following a history of repeated high cortisol responses (Fries, Hesse, Hellhammer & Hellhammer, 
2005). Hypocortisolism is associated with symptoms such as fatigue and pain, so once it has developed it 
could act as a maintaining factor for CFS. 
 
Three previous studies have reported serum cortisol levels in adolescents with CFS, with inconsistent 
findings (Kavelaars, Kuis, Knook, Sinnema & Heijnen, 2000; Wyller, Evang, Godang, Solhjell & Bollerslev, 
2010; Segal, Hindmarsh & Viner, 2005). Each of these studies used a potentially stressful invasive testing 
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procedure in a hospital environment. Given that cortisol is a hormone that shows diurnal variation and is 
secreted in a pulsatile manner, another limitation is the use of a single blood cortisol measurement to assess 
basal HPA axis function. Studies are needed using repeated salivary measures of cortisol over the day, taken 
in a naturalistic home environment that eliminates the confounding stress associated with both intravenous 
cannulation and hospital attendance.  Katz et al. (2013) found little evidence of reduced salivary cortisol 
levels in adolescents with CFS but this had a number of limitations including a very small sample size (nine 
adolescents with CFS), just two measurement points (morning and evening) and the inclusion of adolescents 
who developed CFS after infectious mononucleosis only. Nijhof et al. (2014) found lower cortisol 
awakening response in adolescents with CFS compared to healthy controls but they did not investigate 
cortisol output over the course of the day. This is the first salivary cortisol study to report both total daily 
cortisol output and the cortisol awakening response (CAR) in adolescents with CFS.  
 
Nijhof et al. (2014) compared characteristics of adolescents with CFS dichotomised by below and above 
average AUCg levels and found that only sleep duration before CAR was significantly different. They did 
not find differences in terms of depression but did not compare the groups on other psychological 
characteristics that relate to stress vulnerability such as anxiety or high standards for performance or personal 
conduct. The present study undertook exploratory analyses investigating associations between cortisol output 
and questionnaire measures of perfectionism and prosocial behaviour (as indications of high standards for 
performance and personal conduct) as well as other characteristics such as anxiety, depression, emotional 
and behavioural difficulties and fatigue severity.  
 
Cognitive behavioural treatments are evidence-based interventions for CFS (Chalder, Deary, Husain & 
Walwyn, 2010; Stulemeijer, de Jong, Fiselier, Hoogveld & Bleijenberg, 2004). These interventions are based 
on a multifactorial approach to CFS in adolescents (e.g. Lievesley, Rimes & Chalder, 2014; Surawy, 
Hackmann, Hawton & Sharpe, 1995) in which  it is hypothesised that certain premorbid characteristics, 
including high standards for performance or personal conduct, conscientiousness and stress vulnerability 
(e.g. Rangel, Garralda, Levin, & Roberts, 2000) increase the risk for developing fatigue in the context of 
challenges such as physical illness or extra environmental demands. For example, perfectionist or 
conscientious individuals may strenuously attempt to keep up with their usual standards despite the extra 
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challenges, and end up more stressed and fatigued as a result (e.g. Dittner, Rimes & Thorpe, 2011). It is 
suggested that acute fatigue can become chronic via a number of mechanisms including level of physical 
activity (e.g. too high or too low; ter Wolbeek et al. 2008), fearful beliefs about fatigue or the effects of 
fatigue (e.g. Stahl, Rimes & Chalder, 2014) or emotional difficulties such as anxiety or depression (Rangel, 
Garralda, Hall and Woodham, 2003; Rimes et al., 2007). Cognitive behavioural interventions typically aim 
to improve symptoms and functioning by a) encouraging patients to achieve a balance between activity and 
rest, b) gradually increasing activities, c) establishing a sleep routine, d) addressing unhelpful beliefs (e.g. 
about fatigue or high standards) and e) paying attention to relapse prevention. Although initial studies 
focused on face-to-face treatment, travelling to the clinic can cause extra fatigue, and more recent studies 
have found evidence to support the use of internet-based CBT (Nijhof et al., 2012) and telephone-based 
guided self-help (Lloyd, Chalder, Sallis and Rimes, 2012).  
 
Cognitive behavioural interventions address a number of variables that influence cortisol levels including 
activity patterns and deconditioning, stress, sleep and personality characteristics associated with stress 
vulnerability. A previous study in adults with CFS found that daily cortisol output normalized after cognitive 
behavioural treatment (Roberts, Papadopoulos, Wessely, Chalder & Cleare, 2009). Nijhof et al. (2014) 
reported that adolescents who recovered in their trial after either CBT or “treatment-as-usual” (which might 
have been CBT or graded exercise therapy or a rehabilitation programme) had a significant rise in their 
cortisol awakening response. That paper did not report change in the cortisol awakening response after a 
single type of treatment such as CBT. There have been no previous studies reporting the cortisol awakening 
response after a single type of treatment such as CBT, or changes in cortisol output over the day before and 
after treatment. In the present study we investigated both cortisol output over the day and the cortisol 
awakening response before and after a telephone-based guided self-help cognitive behavioural intervention, 
which was the standard treatment on offer in our clinic at that time. We hypothesized that cortisol output 
would be significantly higher at six months after the end of cognitive behavioural guided self-help than at 
pre-treatment.  
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METHODS 
 
Participants 
Participants were 49 adolescents with CFS, and 36 healthy adolescents who were selected to match for age 
and gender. The CFS group was comprised of patients attending a specialist CFS Unit in London who met 
CDC
 
(Fukuda et al., 1994) and Oxford
 
(Sharpe et al., 1991) criteria for CFS. Assessment at the CFS clinic 
included the exclusion of depression or other psychiatric problems as the primary diagnosis. They had all 
been assessed by paediatricians who had conducted appropriate tests to exclude other possible diagnoses 
causing their fatigue. Self-reported mean duration of CFS was 25.3 months (SD=16.1). Saliva samples were 
taken prior to treatment. The healthy adolescents were recruited via local schools and were required to have 
no history of CFS and no current medical condition likely to cause excessive fatigue. Of the CFS sample, 24 
returned post-treatment questionnaires and cortisol samples; of the remainder, three did not complete 
treatment and the others did not return usable post-treatment cortisol samples or questionnaires or both. 
Independent t-tests indicated that there were no significant differences between participants for whom post-
treatment questionnaire and cortisol data were or were not available, in terms of age, duration of CFS, 
baseline fatigue (Chalder Fatigue Scale; Chalder et al., 1993) or any of the pre-treatment main cortisol 
measures (ts<1.9).   
 
Procedure 
The study was approved by the Institute of Psychiatry (King’s College London) Ethics Committee, reference 
011/00. Written informed consent was obtained from the young people and their parents. Questionnaire 
completion and saliva collection was undertaken at home. Participants were asked to collect the samples on a 
Saturday when they were able to wake up between 06:00 – 09:00. Samples were taken using untreated 
Salivettes. Participants were instructed to provide a sample of saliva immediately after waking, 15 mins, 30 
mins, 45 mins and 60 mins after awakening, then at 12:00, 16:00 and 20:00 hours. Standard collection 
instructions were given, e.g. not to eat or brush teeth in the hour prior to collection. Participants were asked 
to note the time they took the samples and what they had been doing the previous hour before each sample, 
including anything eaten or drunk. Participants not complying with the collection instructions were not 
included. Samples were kept in the refrigerator overnight before being returned to the hospital. Cortisol was 
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measured for a second time at six months after the end of treatment, to allow time for consolidation of the 
treatment response and for any effects on the HPA axis to occur. The same saliva collection procedure was 
used at Time 2. 
 
Treatment 
Treatment consisted of telephone-based guided self-help (described in the Introduction). After face-to-face 
assessment, patients received a self-help manual and up to 6 fortnightly telephone sessions of 30 minutes. 
The primary clinical outcome was school attendance.  
 
Clinical measures 
School attendance, the primary clinical outcome, was calculated as a percentage of the time that they should 
be attending; hours at school and hours they should have attended were self-reported by the young person. 
Questionnaires completed were the Chalder Fatigue Scale (Chalder et al., 1993), the Birleson Depression 
Inventory
 
(Birleson, 1981), the Spence Children’s Anxiety Scale (Spence, 1998) and the Child and 
Adolescent Perfectionism Scale (Flett, Hewitt, Boucher, Davidson & Munro, 2000). The perfectionism 
questionnaire was scored in three subscales in line with previous research findings (O’Connor, Dixon & 
Rasmussen, 1990): self-oriented - striving perfectionism (e.g. “I try to be perfect in everything I do”); self-
oriented - critical perfectionism (e.g. “I get mad at myself when I make a mistake” and socially-prescribed 
perfectionism (e.g. “Other people always expect me to be perfect”). The CFS patients also completed the 
Strengths and Difficulties Questionnaire (SDQ; Goodman, 1997) which provides subscale scores for 
Difficulties (emotional and behavioural) and Prosocial Behaviour (e.g. “I try to be nice to other people”). 
This latter scale was used as a way of assessing high standards for personal conduct. All questionnaires 
except the perfectionism scale were repeated at Time 2. 
 
Cortisol analysis 
Saliva samples were collected as previously described
 
(Roberts, Chalder, Papadopoulos & Cleare, 2004) in 
plain Sarstedt Salivettes which were stored at -40 °C until analysis in the hospital laboratory. Saliva cortisol 
concentrations were determined using the “Immmulite” Siemens’s Immunoassay System; 
www.diagnostics.siemens.com (Mondelli et al., 2010).  
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Statistical Analysis 
Analyses were undertaken using the Statistical Package for Social Sciences (SPSS) version 15. Two-tailed 
tests were used. For the salivary cortisol day curve (the primary outcome), the total output from waking to 
2000 hours was assessed by calculating the area under the curve (AUCday), using the trapezoidal method 
(Pruessner, Kirschbaum, Meinlschmid & Hellhammer, 2003). The mean cortisol over the day (8am, noon, 
4pm and 8pm) was also calculated. To assess the cortisol awakening response, the area under the curve with 
respect to the increase (AUCi) and with respect to the ground (AUCg) were calculated. A third measure of 
the awakening response was calculated by subtracting the immediate awakening value from cortisol at 30 
mins after waking. Change in cortisol responses was calculated by subtracting the values for the second time 
point from the first, e.g. change in AUCday = post-treatment AUCday minus pre-treatment AUCday. 
 
For the pre-treatment group comparisons, AUCday, mean cortisol over the day and AUCg was not normally 
distributed, so were log-transformed prior to independent t-tests. AUCi, CAR as represented by the 
difference between cortisol at 30 mins after waking and immediate waking, the Chalder Fatigue Scale, 
Spence Anxiety Scale, Birleson Depression Inventory, Child and Adolescent Perfectionism Scale and 
Strengths and Difficulties Questionnaire (total difficulties and prosocial) were not normally distributed even 
after log transformation, so non-parametric analyses were used. Kolmogorov-Smirnoff tests were used for 
comparing two groups rather than Mann-Whitney tests as there were ties in the ranked data, and the Mann-
Whitney is based on the assumption of no ties. Cortisol analyses were repeated excluding participants who 
may be depressed, to check whether any group differences could be accounted for by this factor. After 
excluding participants who scored 13 or above, the cut-off for likely depressive disorder on the Birleson 
Depression Inventory (Birleson, 1981), there were 20 CFS patients and 32 HC. Similar analyses involving 
the Birleson Depression Inventory were undertaken in which the item that referred to energy was excluded; 
the results showed a similar pattern and are not reported here. Between-group comparisons were also 
repeated excluding participants taking medications with the potential to affect cortisol production. These 
were doxycycline (n=1), propranolol (n=1), citalopram (n=1), paroxetine (n=1), amitriptyline (n=3), 
pizotifen (migraine medication), melatonin (n=3), and oral contraceptive (n=1). The medication exclusions 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 9 
resulted in groups of 30 CFS and 33 HC participants for the AUCday analyses, and 29 CFS and 34 HC for 
AUCi and AUCg. 
 
For the pre- to post-treatment analyses, AUCday and mean cortisol over the day were log-transformed prior 
to paired t-tests to compare scores before and after treatment. For AUCi and CAR delta (30 mins minus 
waking) pre-post comparisons, the non-normal distribution could not be corrected by transformation so non-
parametric analyses were used (Wilcoxon Signed-Rank Tests).   
 
RESULTS 
 
Baseline demographic and clinical characteristics 
The groups were not significantly different in age, gender or the proportion of female participants who had 
reached menarche (see Table 1). The mean time of waking was 0832h in the CFS group and 0835h in the HC 
group, which was not significantly different (t(62)=-0.20, p=0.84). The day of the menstrual cycle in the CFS 
females (mean=12.1, SD=9.0, if 1 is first day of menstrual bleeding) was not significantly differently 
different from the HC females (mean=14.0, SD=12.6; t(28)=0.47, p=0.644). The CFS participants had 
significantly higher fatigue and depression scores than the HC but were not significantly higher on anxiety or 
perfectionism (see Table 1).  
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Table 1. Sociodemographic, clinical characteristics and cortisol measures for adolescents with CFS and healthy controls  
Variable N  Adolescents with CFS Healthy controls Test statistics 
a 
p 
 
Age 
Gender  (female / male ) 
Menarche reached (females only) 
CFS/HC 
49 / 36 
49 / 36 
31 / 21 
Mean 
14.9 
n = 31 / 18 
n=27  
SD 
1.7 
63 /  37 % 
87% 
Mean 
15.0 
n = 21 / 15 
n=18 
SD 
1.7 
58 / 42 % 
86% 
 
   t(83)=-0.32  
   χ (1) =0.21 
   χ (1) =0.02 
 
 0.748 
 0.645 
 0.886 
 
Chalder Fatigue Scale (Likert) 
Spence Children’s Anxiety Scale  
Birleson Depression Scale 
 
49 / 36 
47 / 36 
45 / 35 
Median 
23.0 
16.0 
13.0 
IQR 
21.0 – 23.0 
9.0 – 34.0 
9.0 – 17.0 
Median 
11.0 
16.5 
5.0 
IQR 
10.3 – 12.8 
8.0 – 22.8 
2.0 –   7.0 
    
       Z=3.90  
       Z=0.73  
       Z=3.09  
 
<0.0005 
  0.668 
<0.0005 
Child & Adol. Perfectionism Scale:  Self-oriented - Striving  
                                                           Self-oriented  -Critical  
                                                           Socially Prescribed  
47 / 33 
47 / 33 
47 / 33 
10.0 
6.0 
14.0 
8.0 – 12.0 
5.0 – 12.0 
  11.0 – 18.0 
12.0 
7.0 
16.0 
10.0 – 13.5   
5.0 – 10.0  
9.5 – 20.5   
Z=1.12  
Z=0.91  
       Z=0.50 
0.106 
0.374 
0.962 
Strengths & Difficulties Q:  Difficulties  
                                             Prosocial behaviour                                           
  48 /  - 
49 / - 
11.0 
  8.0 
9.0 -16.8 
6.0 - 9.0 
    
Cortisol output over day: AUCday (nmol/L h)  
Mean cortisol over the day (8am, noon, 4pm, 8pm; nmol/L) 
Cortisol awakening response – AUCg (nmol/L min) 
Cortisol awakening response – AUCi (nmol/L min) 
Cortisol awakening response –30 mins minus wakening (nmol/L) 
46 / 33 
46 / 33 
47 / 34 
47 / 34 
 47 / 35 
Mean = 63.6 
Mean =  5.6 
Mean =11.7 
Median =0.1 
Median =0.8 
  SD = 22.8  
  SD =   2.0 
  SD =   5.6 
IQR= -1.7 - 4.0 
IQR = -1.9 – 6.6 
Mean = 71.7 
Mean =   6.3 
Mean = 12.0 
Median= -0.3 
Median = 0.6 
  SD = 19.5 
   SD =  1.7 
  SD =   6.2 
IQR=  -3.5 -  2.7 
IQR = -3.3 – 5.4 
     t(77)=2.0 
     t(77)=1.8 
     t(79)=0.3 
       Z=0.76 
       Z=0.81 
0.046 
0.078 
0.797 
0.608 
0.535 
AUCday= area under the curve for the day; AUCg= area under curve with respect to ground; AUCi= area under curve with respect to increase; IQR = Interquartile Range.  
a
 Independent t-test, chi-square analysis or Kolmogorov-Smirnov test.  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 11 
Cortisol excretion during the day 
Saliva cortisol concentrations were numerically lower in the CFS group than the healthy participants at all 
time-points (see Figure 1) but significantly so at only 4pm (Z=1.70, p=0.006). The primary outcome, total 
cortisol output over the day (AUCday) was significantly lower in the CFS group than the HC group. (See 
Table 1. This group difference in AUCday remained if participants were excluded for having a score of 13 or 
higher on the Birleson Depression Inventory (Z=1.56, p=0.016) or for taking medications that may affect 
cortisol levels (Z=1.38, p=0.044). (Non-parametric analyses were used because logAUCday was not 
normally distributed for these samples). There was a non-significant trend for mean cortisol over the day to 
be lower in the CFS group (See Table 1).  
 
Figure 1 about here 
 
 
Associations between daily cortisol output (AUCday) and other characteristics 
As the above results had indicated AUCday to be significantly reduced in the CFS group, exploratory 
investigations using Spearman’s correlations were conducted to examine whether this cortisol measure was 
associated with clinical characteristics within this group. There was a significant association between 
AUCday and Self-Oriented Perfectionist Striving (Spearman’s rho (rs)=-0.298, p=0.050) and SDQ prosocial 
behaviour (rs = -0.425, p=0.003). AUCday was not significantly associated with Socially Prescribed 
Perfectionism (rs=0.08), Self-Oriented Perfectionism Critical (rs=-0.10), SDQ Difficulties (rs=1.0), Chalder 
Fatigue Scale (rs=0.06), Birleson Depression Inventory (rs=0.05) or Spence Children’s Anxiety Scale (rs=-
0.10). There was no association between AUCday and duration of CFS (rs=-0.09) or gender differences in 
AUCday (Z=0.85, p=0.468). For the healthy control group, there were no significant correlations between 
AUCday and questionnaire scores; the largest value for rs was 0.29 (p=0.120) for the association for Self-
Oriented Perfectionist Striving, which is in the opposite direction than in the CFS group. 
 
Cortisol awakening response (CAR) 
There were no significant differences between the two groups in terms of the area under the curve with 
respect to the increase (AUCi) or with respect to the ground (AUCg); see Table 1. Similarly, there were no 
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group differences if participants were excluded who scored 13 or above on the Birleson Depression 
Inventory or who were taking medication that might affect cortisol. There were no significant correlations 
between measures of CAR and questionnaire measures.  
 
Change in clinical outcomes after treatment 
There was a significant improvement in school attendance, the primary clinical outcome, from 24% to 49% 
(Z(24)=-2.5, p=0.012). The reduction on the Chalder Fatigue Scale (mean=24 (SD=5) to mean=21 (SD=21)) 
did not reach significance (t(23)=1.5, p=0.14). There was a significant reduction on the Spence Children’s 
Anxiety Scale (mean=22 (SD=17) to mean=17 (SD14); t(21)=2.1, p=0.005). The Birleson Depression Scale 
(excluding Q7 about energy) also showed a significant decrease (mean=11 (SD=6) to mean=8 (SD=5); 
t(23)=2.1, p=0.044).  There were no significant changes on the SDQ scales (Zs<2.0).  
 
Cortisol levels after treatment 
The primary cortisol outcome was the AUCday and a paired t-test indicated that this had significantly 
increased (by 24%) after treatment (see Table 2). Post-treatment AUCday for the CFS patients was not 
significantly different from the AUCday for HC reported in Table 1 (Z=0.786, p=0.567). The cortisol 
awakening response showed no significant change after treatment; see Table 2.  
 
Table 2. Salivary cortisol measures before and after treatment in adolescents with CFS 
 
 n Pre-treatment Post-treatment Test statistic
a
   P value 
 
Cortisol output: Area Under the 
Curve for the Day
b
 (nmol/L h) 
 
21 
 Mean   (SD) 
 58.0   (14.9) 
 Mean     (SD) 
  72.0     (28.2) 
 
t= -2.2   
 
0.039* 
Mean value across the day
b
  
(8am, noon, 4pm, 8pm; nmol/L) 
21     5.3    (1.4)     6.4      (2.7) t= -1.7   0.109 
 
Cortisol Awakening Response - 
Area Under the Curve with 
respect to the ground (nmol/L 
min) 
24  12.2      (4.5)   12.7      (5.4) t= -0.5   0.613 
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Cortisol Awakening Response – 
Area Under the Curve with 
respect to the increase (nmol/L 
min) 
24  Median   (IQR) 
-0.14   (-1.6, 5.1) 
Median   (IQR) 
  0.74     (-1.6, 4.0) 
 
Z= -0.5  
 
0.648 
Cortisol Awakening Response – 
delta (30 mins minus waking; 
nmol/L) 
24   1.00  (-1.98 – 
7.2) 
 1.55  (-1.78 – 5.8) Z= - 0.386 0.700 
a 
Paired t-test or Wilcoxon Signed-Rank Test   
b
 Log transformed prior to paired t-test 
 
Associations between changes in cortisol output and clinical measures  
Exploratory correlational analyses were undertaken to investigate possible associations between change in 
AUCday and clinical variables. There were no significant associations between changes in AUCday and 
changes between pre-treatment and six-month follow-up on percentage school attendance, Chalder Fatigue 
Scale, Birleson Depression Inventory, Spence Children’s Anxiety Scale, SDQ Difficulties or SDQ Prosocial 
scales (all correlation coefficients < 0.36).    
 
 
DISCUSSION 
 
This is the first study to report that adolescents with CFS have significantly lower saliva cortisol secretion 
over the course of the day than age and gender-matched healthy controls. This is in line with research in 
adults with CFS (Jerjes et al., 2005). Lower daily cortisol output was associated with two psychological 
characteristics in the CFS participants: perfectionist striving and prosocial behaviour (kind, considerate, 
helpful and sharing behaviours). As far as the authors are aware, this is the first demonstration of 
associations between daily cortisol output and these characteristics, in young people or adults, in relation to 
CFS or other populations. In adults in the general population there is some evidence that perfectionism may 
be associated with higher cortisol responses to acute stressors in the laboratory (e.g. Wirtz et al., 2007), but it 
is possible that chronic stress may lead to a longer-term blunting of the cortisol response (Miller, Chen & 
Zhou 2007). In the present study, the association between mild hypocortisolism and perfectionism or 
prosocial behaviour may reflect a chronic stress response related to attempts to keep up high standards of 
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performance or personal conduct, in line with cognitive behavioural approaches to CFS (e.g. Lievesley, 
Rimes & Chalder, 2014; Surawy, Hackmann, Hawton & Sharpe, 1995). Indeed, in adults there is evidence 
from a prospective study that perfectionism at the time of a virus is associated with increased risk for CFS 
(Moss-Morris, Spence & Hou, 2011). It is possible that cortisol disturbance is one of the mechanisms 
underlying this relationship. However, the associations between cortisol and perfectionism and prosocial 
behaviour in the present study were the result of exploratory analyses and require replication in a second, 
larger sample, in which perceived stress should also be assessed. In the healthy control group, although the 
association between AUCday and perfectionist striving was not quite significant, it was in the opposite 
direction to that observed in the CFS group, with greater striving being positively associated with AUCday in 
healthy adolescents. There have been previous findings of different patterns of associations with 
perfectionism in adults with CFS than in healthy controls (Deary and Chalder, 2008), highlighting the need 
for an improved understanding about how perfectionism may be helpful or unhelpful for different 
populations or in different contexts. 
 
Daily cortisol output (AUCday) increased significantly after cognitive behavioural guided self-help for 
chronic fatigue syndrome in adolescents. This is the first time that post-CBT daily cortisol output changes 
have been reported in adolescents with this condition. The findings are consistent with a previous study in 
adults with CFS which also found an increase in daily cortisol output after cognitive behavioural treatment 
(Roberts et al., 2009). Post-treatment AUCday for the CFS patients was not significantly different to 
AUCday for the healthy controls measured in the first part of the study. As this change took place within the 
context of a non-randomised cohort study, it cannot be concluded that the intervention was necessarily 
responsible for the normalisation of the daily cortisol output. However, the improvement after the cognitive 
behavioural intervention is encouraging, especially because hydrocortisone treatment cannot be 
recommended; research in adults has found limited evidence of benefit, together with loss of effects after 
discontinuation, and adrenal suppression as a side-effect (McKenzie et al., 1998; Cleare et al., 1999; 
Blockmans, Persoons, Van Houdenhove, Lejeune & Bobbaers, 2003). Comparison with an untreated CFS 
group would be necessary to clarify whether cortisol changes could have been due to natural course, but it 
was not considered ethical to withhold treatment, particularly as CFS can have such profound effects on 
socioemotional, educational and other aspects of development. Future research should examine cortisol 
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changes before and after a CBT intervention compared to a control intervention. Another limitation was that 
the Strengths and Difficulties Questionnaire was not administered in the healthy control group. We found no 
association between changes in cortisol output and changes in school attendance, fatigue, depression, 
anxiety, general emotional / behavioural difficulties or prosocial behaviour. Future studies should investigate 
the role of other possible explanatory factors including activity levels and sleep disturbance. 
 
In contrast to the findings for daily cortisol output, there were no significant differences between adolescents 
with CFS and healthy controls for the salivary cortisol response to waking, unlike Nijhof et al. (2014). The 
reason for this is unclear but there were several differences between that study and the current one. For 
example, in the previous study, participants had been instructed to stay lying in bed for an hour after waking, 
and data was collected on a week day rather than the weekend. In the present study participants were asked 
to collect data on a day on which they were able to wake up between 06:00 and 09:00 whereas no time 
instructions were given by Nijhof et al. (2014) and they found that sleep duration was longer in their CFS 
group than the healthy controls. Future studies need to examine further a wide range of factors that may be 
affecting both the cortisol awakening response and data collection. 
 
Strengths of the study include the use of a healthy control group matched for age, gender, menarche status, 
day of menstrual cycle and awakening time. Other confounding and explanatory factors such as body mass 
index, perceived stress and trauma experiences should be measured in future research. The CFS patients 
were consecutive attendees at a specialist CFS clinic but may not be representative of adolescents with CFS 
in other health clinics or the community. The cross-sectional design cannot address the issue of whether 
cortisol disturbance is a primary etiological factor; to address this issue, prospective designs are required. 
Further limitations are the sample size, which meant that some of the changes on clinical questionnaires did 
not reach statistical significance, unlike in the previous study investigating this guided self-help intervention 
with a larger sample (Lloyd et al., 2011).  Furthermore, not all adolescents with CFS provided a cortisol 
sample at follow-up. Analyses investigating the relationship between cortisol measures and clinical variables 
were not adjusted for multiple testing due to the exploratory nature of these investigations; this increases the 
risk of false positives, so the findings require replication in future research. 
 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 16 
Conclusions 
Following this evidence of reduced daily cortisol output in female adolescents with CFS who have passed 
the menarche, further research into the potential role of hypocortisolism in the development or maintenance 
of CFS in adolescence is needed. The association between daily cortisol output and two psychological 
variables, perfectionist striving and prosocial behaviour, is a novel finding that requires replication. It was 
encouraging to find that the reduced daily cortisol output in adolescents with CFS had normalised six months 
after a course of cognitive behavioural treatment.  
 
 
 
 
 
Acknowledgements 
 
Trudie Chalder and Anthony Cleare acknowledge financial support from the National Institute for Health 
Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS 
Foundation Trust and King's College London. The views expressed are those of the authors and not 
necessarily those of the NHS, the NIHR or the Department of Health. We are very grateful to Anna 
Silverman for her help recruiting healthy adolescents and to Irene Papadopoulos for the cortisol analyses. We 
would also like to thank the Unit research assistants for assistance with data collection and entry. 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 17 
References 
 
Birleson, P. (1981). The Validity of Depressive Disorder in Childhood and the Development of a Self-Rating  
 Scale: A Research Report. Journal of Child Psychology and Psychiatry, 22, 73-88. 
Blockmans, D., Persoons, P., Van Houdenhove, B., Lejeune, M., & Bobbaers, H. (2003). Combination  
 therapy with hydrocortisone and fludrocortisones does not improve symptoms in chronic fatigue  
 syndrome: a randomized, placebo controlled, double-blind, crossover study. American Journal of 
 Medicine, 114, 736–741. 
Bould, H., Collin, S.M., Lewis, G., Rimes, K., Crawley, E. (2013). Depression in paediatric chronic fatigue  
syndrome.  Archives of Diseases in Childhood, 98, 425-428. 
Chalder, T., Berelowitz, G., Pawlikowska, T., Watts, L., Wessely, S., Wright, D., Wallace, P. (1993).  
Development of a fatigue scale. Journal of Psychosomatic Research, 37, 147-13. 
Chalder, T., Deary, V., Husain, K., & Walwyn, R. (2010) Family-focused cognitive behaviour therapy versus  
 psycho-education for chronic fatigue syndrome in 11- to 18-year-olds: a randomized controlled  
 treatment trial. Psychological Medicine, 40, 1269-1279. 
Cleare, A.J., Heap, E., Malhi, G.S., Wessely, S., O’Keane, V., & Miell, J. (1999). Low-dose hydrocortisone  
 in chronic fatigue syndrome: a randomized crossover trial. Lancet, 353, 455–458. 
Clow A, Hucklebridge F, Stalder T, Evans P, Thorn L. (2010). The cortisol awakening response: more than a  
measure of HPA axis function. Neuroscience & Biobehavioral Reviews , 35, 97–103 
Deary, V. & Chalder, T. (2010). Personality and perfectionism in chronic fatigue syndrome: A closer look.  
Psychology & Health, 25, 465-475. 
Dittner, A.J., Rimes, K.A., & Thorpe, S. (2011). Negative perfectionism increases the risk of  
fatigue following a period of stress, Psychology & Health, 26, 253-68. 
Flett, G., Hewitt P.L., Boucher, D.J., Davidson, L.A., Munro, Y. (2000). The Child-Adolescent  
Perfectionism Scale: Development, Validation, and Association with Adjustment. Unpublished  
manuscript. 
Fries, E., Hesse, J., Hellhammer, J., Hellhammer, D.H. (2005). A new view on hypocortisolism.  
Psychoneuroendocrinology, 30, 1010–1016. 
Fukuda, K., Straus, S.E., Hickie, I., Sharpe, M.C., Dobbins, J.D., & Komaroff, A. (1994). The chronic  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 18 
 fatigue syndrome: a comprehensive approach to its definition and management. Annals of Internal
 Medicine, 121, 953-9. 
Goodman, R. (1997). The Strengths and Difficulties Questionnaire: A Research Note. Journal of Child  
Psychology and Psychiatry, 38, 581-586. 
Gray, S.E., Rutter, D.R. (2007). Illness representations in young people with Chronic Fatigue Syndrome.  
Psychology and Health, 22, 159-174. 
Heim, C., Nater, U.M., Maloney, E., Boneva, R., Jones, J.F., & Reeves, W.C. (2009). Childhood Trauma and  
 Risk for Chronic Fatigue Syndrome. Archives of General Psychiatry; 66, 72-78. 
Jerjes, W.K., Cleare, A.J., Wessely, S., Wood,  P.J., & Taylor, N.F. (2005). Diurnal patterns of salivary  
 cortisol and cortisone output in chronic fatigue syndrome.  Journal of Affective Disorders, 87, 299- 
304. 
Jerjes, W., Peters, T., Taylor, N., Wessely, S., & Cleare, A. (2006). Diurnal excretion of urinary cortisol,  
 cortisone and cortisol metabolites in chronic fatigue syndrome. Journal of Psychosomatic Research,  
60, 145-153. 
Katz, B.Z., Zimmerman, D., Gorman, M.R.G., Mears, C.J., Shiraishi, Y., & Taylor, R. (2013). Normal  
 Salivary Cortisol and NK Cell Function in Adolescents With Chronic Fatigue Syndrome Following  
 Infectious Mononucleosis. Archives of Pediatric Infectious Diseases, 1, 211-216 
Kavelaars, A., Kuis, W., Knook, L., Sinnema, G., & Heijnen, C.J. (2000). Disturbed Neuroendocrine- 
 Immune Interactions in Chronic Fatigue Syndrome. Journal of Clinical Endocrinology and  
Metabolism, 85, 692-696. 
Lievesley, K., Rimes, K.A. & Chalder, T. (2014). A review of the predisposing, precipitating and 
perpetuating factors in Chronic Fatigue Syndrome in adolescents. Clinical Psychology Review, 34, 
233-248. 
Lloyd, S., Chalder, T., Sallis, H.M., & Rimes, K.A. (2012). Telephone-based guided self-help for  
 adolescents with chronic fatigue syndrome: A non-randomised cohort study. Behaviour Research  
and Therapy, 50, 304-312. 
McKenzie, R., O’Fallon, A., Dale, J., et al. (1998). Low-dose hydrocortisone for treatment of chronic fatigue  
 syndrome: a randomized controlled trial. Journal of the American Medical Association, 280, 1061– 
1066. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 19 
Miller, G.E., Chen, E., Zhou, E.S. (2007). If it goes up, must it come down? Chronic stress and the  
hypothalamic-pituitary-adrenal axis in humans. Psychological Bulletin, 133, 25–45. 
Moss-Morris, R., Spence, M.J., Hour, R. (2011). The pathway from glandular fever to chronic fatigue  
syndrome: can the cognitive behavioural model provide the map? Psychological Medicine, 41, 1099 
Nijhof, S.L., Rutten, J.M., Uiterwaal, C.S., Bleijenberg, G., Kimpen, J.L., Putte, E.M.. (2014). The role of  
hypocortisolism in chronic fatigue syndrome. Psychoneuroendocrinology, 42,199-206. 
Nijhof, S.L., Bleijenberg, G.,  Uiterwaal, C.S.P.M.,  Kimpen, J.L.L.,  van de Putte, E.M. (2012).  
Effectiveness of internet-based cognitive behavioural treatment for adolescents with chronic fatigue  
syndrome (FITNET): a randomised controlled trial. Lancet, 379, 1412-18. 
O'Connor, R.C., Dixon, D., Rasmussen, S. (2009). The Structure and Temporal Stability of the Child and  
Adolescent Perfectionism Scale. Psychological Assessment, 21, 437-443. 
Papadopoulos, A.S. & Cleare, A.J. (2012). Hypothalamic–pituitary–adrenal axis dysfunction in chronic  
 fatigue syndrome. Nature Reviews Endocrinology, 8, 22-32. 
Pruessner, J.C., Kirschbaum, C., Meinlschmid, G., & Hellhammer, D.H. (2003). Two formulas for  
 computation of the area under the curve represent measures of total hormone concentration versus  
 time-dependent change. Psychoneuroendocrinology, 28, 916-931. 
Rangel, L., Garralda, M.E., Hall, A., Woodham, S. (2003). Psychiatric adjustment in chronic fatigue  
syndrome of childhood and in juvenile idiopathic arthritis. Psychol. Med. 33, 289-297. 
Rangel, L., Garralda, E., Levin, M., & Roberts, H. (2000). Personality in adolescents with Chronic Fatigue  
Syndrome. European Child and Adolescent Psychiatry, 9, 39–45. 
Rimes, K. A., Goodman, R., Hotopf, M., Wessely, S., Meltzer, H., & Chalder, T. (2007). Incidence,  
prognosis, and risk factors for fatigue and chronic fatigue syndrome in adolescents: A prospective  
community study. Pediatrics, 119(3), 603–609. 
Roberts, A.D.L., Chalder, T., Papadopoulos, A., & Cleare, A.J. (2004). Salivary cortisol response to  
 awakening in chronic fatigue syndrome. British Journal of Psychiatry, 184, 136-141. 
Roberts, A.D.L., Papadopoulos, A.S., Wessely, S., Chalder, T., & Cleare, A.J. (2009). Salivary cortisol  
output before and after cognitive behavioural therapy for chronic fatigue syndrome. Journal of 
Affective Disorders, 115, 280-286. 
Segal, T.Y., Hindmarsh, P.C., & Viner, R.M. (2005). Disturbed adrenal function in adolescents with chronic  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 20 
 fatigue syndrome. Journal of Pediatric Endocrinology and Metabolism, 18, 295-301. 
Sharpe, M.C., Archard, L.C., Banatvala, J.E., Borysiewicz, L.K., Clare, A.W., David, A., Edwards, R.H.,   
Hawton, K.E.,  Lambert, H.P., & Lane, R.J. (1991). A report – chronic fatigue syndrome: guidelines  
 for research. Journal of the Royal Society of Medicine, 84, 118-121. 
Spence, S.H. (1998). A measure of anxiety symptoms among children. Behaviour Research and Therapy,  
36, 545-566. 
Stahl, D., Rimes, K.A., Chalder, T. (2014). Mechanisms of change underlying the efficacy of cognitive  
behaviour therapy for chronic fatigue syndrome in a specialist clinic: A mediation analysis.  
Psychological Medicine, 44, 1331 – 1344. 
Stulemeijer, M., de Jong, L.W.A.M., Fiselier, T.J.W., Hoogveld, S.W.B., & Bleijenberg, G. (2004).  
 Cognitive behaviour therapy for adolescents with chronic fatigue syndrome: randomised controlled 
 trial. British Medical Journal, 330, 14 
Surawy, C., Hackmann, A., Hawton, K., Sharpe, M. 1995.Chronic fatigue syndrome: a cognitive approach.  
Behaviour Research and Therapy, 33, 535–44 
Tak, L.M., Cleare, A.J., Ormel, J., Manoharan, A., Kok, I.C., Wessely, S., & Rosmalen, J.G.M.  
 (2011). Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in  
functional somatic disorders. Biological Psychology, 87, 183-94.  
Ter Wolbeek, M., van Doomen, L.J.P., Kavelaars, A.,  Heijnen, C.J. (2008). Predictors of Persistent and  
New-onset Fatigue in Adolescent Girls. Pediatrics, 12, e449 -e457 
Wirtz, P.E., Elsenbruch, S., Emini, L., Rüdisüli, K., Groessbauer, S., Ehlert, U. (2007). Perfectionism and the  
Cortisol Response to Psychosocial Stress in Men. Psychosomatic Medicine, 69, 249–255 
Wyller, V.B., Evang, J.A., Godang, K., Solhjell, K.K., & Bollerslev, J. (2010). Hormonal alterations in  
 adolescent chronic fatigue syndrome. Acta Paediatrica, 99,770-3. 
 
 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 21 
 
Figure 1. Mean salivary cortisol over the day in adolescents with CFS and healthy adolescents 
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Highlights 
 Salivary cortisol was investigated in adolescents with chronic fatigue syndrome.  
 Reduced salivary cortisol output over the day was found.  
 Cortisol output was associated with perfectionism and prosocial behaviour. 
 The adolescents received cognitive behavioural guided self-help treatment.  
  
 By six months post-treatment, cortisol output had increased up to normal levels.  
